Fmoc-L-Lys(Boc,Me)-OH

Fmoc-L-Lys(Boc,Me)-OH is an Fmoc-protected, side-chain-modified lysine derivative in which the α-amino group and carboxyl group are configured for amino-acid building-block use, featuring an L-lysine backbone with a protected ε-amino side chain bearing Boc and a methyl substitution (Me). The molecule contains an Fmoc carbamate on the α-amino functionality, a Boc-protected ε-amino group, and a free carboxylic acid, with the side-chain modification providing controlled chemoselectivity by masking the ε-amine during stepwise peptide assembly. In peptide synthesis workflows, it functions as a protected lysine building block for introducing a methylated, Boc-protected ε-amino lysine residue while maintaining orthogonal protection patterns that support sequential coupling and deprotection strategies.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Fmoc-L-Lys(Boc,Me)-OH(CAS 951695-85-5)

CAT No: CP26108

CAS No:951695-85-5

Synonyms/Alias:951695-85-5;FMOC-LYS(ME,BOC)-OH;Fmoc-Lys(Boc,Me)-OH;FMOC-LYS(BOC)(ME)-OH;Nalpha-Fmoc-Nepsilon-methyl-Nepsilon-Boc-L-lysine;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]hexanoic acid;Fmoc-Lys(Me)(Boc)-OH;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)(methyl)amino)hexanoic acid;MFCD01861332;(2S)-6-[(tert-butoxycarbonyl)(methyl)amino]-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}hexanoic acid;N'-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N'-methyl-L-lysine;Fmoc-Lys (Boc) (Me)-OH;SCHEMBL12346100;DTXSID70657020;CS-D0016;AKOS016002232;N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-N6-methyl-L-lysine;AC-24661;AS-19666;HY-66024;DB-030099;S-951695-85-5;(S)-2-Amino-6-(methylamino)hexanoic acid, N6-BOC, N2-FMOC protected;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-t-butyl-oxycarbonyl-N-epsilon-methyl-L-lysine (Fmoc-L-Lys(Boc,Me)-OH);N~6~-(tert-Butoxycarbonyl)-N~2~-{[(9H-fluoren-9-yl)methoxy]carbonyl}-N~6~-methyl-L-lysine;

Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-t-butyloxycarbonyl-N-epsilon-methyl-L-lysine

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C27H34N2O6
M.W/Mr.
482.6
Application
Peptide synthesis; Drug screening

Fmoc-L-Lys(Boc,Me)-OH is an Fmoc-protected lysine derivative bearing a Boc-protected side-chain amine and a methyl substituent on the ε-position, defining a chiral amino acid building block for peptide chemistry. The structure contains an N-terminal fluorenylmethoxycarbonyl (Fmoc) carbamate that can be removed under base, a C-terminal carboxylic acid for coupling, and orthogonally protected functionality that preserves the ε-amino group as a Boc carbamate during standard peptide assembly. The ε-methyl substituent introduces steric and electronic differentiation at the side chain, enabling controlled access to a substituted lysine motif after deprotection. The combination of protected amine chemistry and a defined stereocenter makes the compound suitable as a chiral intermediate for amino acid derivatization, peptide analog construction, and downstream functionalization of lysine-like side chains.

1. Peptide Synthesis

Fmoc-L-Lys(Boc,Me)-OH is applied in solid-phase peptide synthesis and peptide fragment assembly where orthogonal protection is required for lysine side-chain handling. The Fmoc group supports Nα-activation and stepwise chain elongation, while the Boc-protected ε-amine remains protected under typical coupling and deprotection cycles until selective removal is desired. The C-terminal carboxylic acid participates in amide bond formation, and the ε-methyl substitution can be retained to generate methylated lysine residues in peptide libraries and sequence-defined analogs. The resulting peptides can be used to probe how steric modulation at the lysine side chain affects folding, binding, and chemical stability, while the protected amino acid format aligns with routine peptide building block workflows.

2. Side-Chain Functionalization

Fmoc-L-Lys(Boc,Me)-OH is used for side-chain functionalization strategies that start from a protected, methyl-substituted lysine scaffold. The ε-Boc carbamate provides a controlled handle for later deprotection, enabling subsequent conversion of the ε-amino functionality into amide, urea, sulfonamide, or other nitrogen-containing linkages while keeping the peptide-compatible Nα protection logic separate. The ε-methyl substituent can influence nucleophilicity and steric approach during derivatization, supporting structure-controlled generation of substituted lysine derivatives for biochemical probes and synthetic intermediates. Downstream transformation of the deprotected side chain supports access to conjugation-ready amino groups and enables systematic exploration of side-chain chemistry in applied amino acid derivatization and peptidomimetic synthesis.

3. Chemical Biology Probes

Fmoc-L-Lys(Boc,Me)-OH is relevant to chemical biology research that requires defined lysine-like residues for labeling, affinity reagents, and molecular recognition studies. The orthogonally protected amine pattern supports incorporation into peptides or peptide-like constructs followed by selective unveiling of the ε-amino group for attachment of tags such as fluorophores, biotin analogs, or affinity handles. The methylated ε-substitution provides an additional stereochemical and steric element that can modulate binding interactions and labeling reactivity, supporting more controlled probe design than unsubstituted lysine analogs. The protected amino acid derivative format also facilitates preparation of sequence-specific conjugates and analytical standards used in mapping, competition assays, and characterization of labeled biomolecular systems.

4. Peptidomimetics And SAR

Fmoc-L-Lys(Boc,Me)-OH is employed in peptidomimetic construction and structure-activity relationship studies where lysine side-chain geometry and substitution pattern are explicitly encoded. The Fmoc-protected Nα position enables incorporation into defined scaffolds, while the Boc-protected ε-amine allows late-stage functional group installation without disturbing the peptide backbone during assembly. The ε-methyl substituent can be used to tune conformational preferences and steric profiles in peptide analogs, supporting SAR campaigns that compare substituted versus unsubstituted lysine motifs. The compound thus functions as a chiral amino acid intermediate for generating libraries of methylated lysine-containing analogs suitable for SAR-driven optimization and synthetic methodology development.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-L-Lys(Boc,Me)-OH is suitable for pharmaceutical intermediate preparation where protected amino acid derivatives are required for scalable, controlled synthesis of nitrogen-rich building blocks. The Fmoc carbamate and Boc-protected side-chain amine provide orthogonal protection logic that can be mapped onto manufacturing-compatible deprotection and coupling steps, supporting reproducible access to methyl-substituted lysine motifs. The presence of a free carboxylic acid enables conversion into activated coupling forms for downstream amide formation, supporting intermediate generation for peptide-based active ingredients, peptide conjugates, or process-manufactured reference materials. The defined stereochemistry and protected functional groups support consistent incorporation into larger synthetic sequences, aligning with industrial fine chemical synthesis practices for amino acid-derived intermediates.

6. Process Chemistry And Fine Synthesis

Fmoc-L-Lys(Boc,Me)-OH is applied in process chemistry and fine chemical synthesis as a chiral amino acid intermediate for manufacturing routes that depend on orthogonally protected amines. The stable Fmoc carbamate under coupling conditions and the Boc-protected ε-amine enable controlled sequencing of protection removal and functional group transformations during multistep synthesis. The methyl-substituted ε-position can be leveraged to produce substituted lysine derivatives that serve as intermediates for further derivatization, including conversion to protected amide-forming derivatives or conjugation-ready amines. The compound's peptide building block compatibility supports integration into larger synthetic workflows, enabling reliable generation of methylated lysine-containing intermediates used across applied amino acid chemistry and industrial chemical manufacturing.

Size
250 mg;1 g;
InChI
InChI=1S/C27H34N2O6/c1-27(2,3)35-26(33)29(4)16-10-9-15-23(24(30)31)28-25(32)34-17-22-20-13-7-5-11-18(20)19-12-6-8-14-21(19)22/h5-8,11-14,22-23H,9-10,15-17H2,1-4H3,(H,28,32)(H,30,31)/t23-/m0/s1
InChI Key
JHMSFOFHTAYQLS-QHCPKHFHSA-N
Canonical SMILES
CC(C)(C)OC(=O)N(C)CCCCC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServiceCustom Conjugation ServicePeptide Modification ServicesPeptide Nucleic Acids SynthesisEpitope Mapping ServicesPeptide CDMOPeptide Analysis ServicesPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers